CD19 antibodies and their uses

Details for Australian Patent Application No. 2006262232 (hide)

Owner Medarex, Inc.

Inventors Bell, Alasdair Fraser; Huang, Haichun; Liu, Jie; Rao-Naik, Chetana; Chen, Sharline; King, David John; Passmore, David B.; Pan, Chin; Cardarelli, Josephine M.; Thi Do, To Uyen

Agent Davies Collison Cave

Pub. Number AU-A-2006262232

PCT Pub. Number WO2007/002223

Priority 60/748,956 08.12.05 US; 60/692,531 20.06.05 US; 60/804,083 06.06.06 US

Filing date 20 June 2006

Wipo publication date 4 January 2007

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/002223 Priority application(s): WO2007/002223

7 August 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Bell, Alasdair Fraser; Huang, Haichun; Liu, Jie; Rao-Naik, Chetana; Chen, Sharline; King, David John; Passmore, David B.; Pan, Chin; Tanamachi, Dawn M.; Cardarelli, Josephine M. and Thi Do, To Uyen

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006262233-Method and apparatus for delivering an implantable wireless sensor for in vivo pressure measurement

2006262231-PSMA antibody-drug conjugates